Chongqing Pharscin Pharmaceutical Co., Ltd.
SZSE:002907.SZ
16.07 (CNY) • At close October 26, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||
| Nettowinst
| 32.699 | 98.401 | 91.78 | 119.187 | 169.746 | 137.372 | 111.987 | 95.708 | 72.688 | 59.304 | 28.947 |
| Afschrijvingen & Amortisatie
| 82.106 | 74.693 | 69.839 | 46.895 | 23.656 | 21.57 | 20.793 | 19.359 | 16.69 | 13.985 | 0 |
| Uitgestelde Inkomstenbelasting
| 0 | -1.672 | 1.454 | -6.792 | -6.442 | -1.146 | -1.184 | -0.443 | 2.194 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | -1.409 | 4.023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| 95.826 | -182.945 | -99.037 | -64.327 | -133.711 | -129.352 | -52.256 | -63.299 | -27.608 | -60.346 | 0 |
| Vorderingen
| 84.862 | -85.87 | -16.388 | 68.32 | -26.737 | -17.823 | 3.152 | -70.616 | 29.065 | -75.217 | 0 |
| Voorraden
| -38.019 | 11.421 | -8.708 | -32.349 | -29.877 | -5.374 | -8.272 | -2.562 | -3.762 | -8.89 | 0 |
| Crediteuren
| 45.633 | -106.825 | -75.394 | -93.506 | -70.656 | -105.009 | -45.952 | 10.322 | -55.105 | 0 | 0 |
| Overig Werkkapitaal
| 3.35 | -1.672 | 1.454 | -6.792 | -6.442 | -123.978 | -43.984 | -60.738 | -23.846 | -51.456 | 0 |
| Overige Niet-Contante Posten
| 8.71 | 22.896 | 20.223 | 14.652 | 6.225 | 2.205 | 0.816 | 5.965 | 4.331 | 7.277 | -28.947 |
| Kasstroom uit Operationele Activiteiten
| 219.341 | 13.045 | 82.851 | 113.638 | 65.916 | 31.795 | 81.34 | 57.733 | 66.101 | 20.221 | 0 |
| Investeringsactiviteiten: | |||||||||||
| Investeringen in Materiële Vaste Activa
| -92.818 | -60.619 | -56.64 | -46.689 | -64.662 | -36.3 | -41.873 | -16.691 | -16.196 | -13.786 | -19.063 |
| Netto Overnames
| 0 | 0 | 0 | 46.692 | 64.67 | 36.306 | 42.023 | 0 | 0.002 | 9.49 | 0 |
| Aankoop van Beleggingen
| -65.389 | -77.96 | -113 | -265.5 | -465 | -274 | -488.8 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0.377 | 133.287 | 61.097 | 399.516 | 259.983 | 453.84 | 313.83 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | 0 | 0 | -46.689 | -64.662 | -36.3 | -41.873 | -16.691 | 0.002 | 0 | 0.003 |
| Kasstroom uit Investeringsactiviteiten
| -157.83 | -5.293 | -108.542 | 87.33 | -269.672 | 143.546 | -216.693 | -16.691 | -16.194 | -4.296 | -19.06 |
| Financieringsactiviteiten: | |||||||||||
| Schuldaflossingen
| 0 | 0 | -12 | 0 | -48.7 | 30.288 | -28 | 0 | -50.9 | 14.3 | -17.2 |
| Uitgifte van Gewone Aandelen
| 0 | 9.151 | 0.227 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | -7.11 | -0.227 | -0.414 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -30.166 | -20.004 | -11.247 | -17.675 | -14.002 | -29.614 | -1.099 | -2.488 | -3.522 | -5.214 | -5.18 |
| Overige Financieringsactiviteiten
| -0.064 | -12.342 | -0.031 | 13.702 | 310.882 | -0 | 146.542 | 2 | 5.055 | -11.805 | 0 |
| Kasstroom uit Financieringsactiviteiten
| -30.229 | -32.346 | -25.658 | -6.089 | 247.342 | 0.674 | 117.444 | -0.488 | -49.367 | -2.72 | -22.38 |
| Overige Informatie: | |||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.071 | 0.352 | -0.088 | -0.27 | -0.105 | 0 | -0 | -0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| 31.838 | -24.241 | -51.437 | 194.609 | 43.48 | 176.016 | -17.91 | 40.554 | 0.54 | 13.205 | 5.898 |
| Kaspositie aan het Einde van de Periode
| 437.565 | 405.726 | 429.968 | 481.405 | 286.796 | 243.316 | 67.301 | 85.21 | 44.656 | 44.116 | 30.911 |